Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy-Reference-Cited by-同舟云学术

Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy

Published:2011-08-05 Issue:10 Volume:66 Page:2372-2378
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:Journal of Antimicrobial Chemotherapy

Author:

Pavie J.,Porcher R.,Torti C.,Medrano J.,Castagna A.,Valin N.,Rusconi S.,Ammassari A.,Ghosn J.,Delaugerre C.,Molina J.-M.,Franzetti M.,Lascoux-Combes C.,Lorenzini P.,Carosi G.,Albini L.,Nasta P.,Quiros-Roldan E.,Castelnuovo F.,Rachline A.,

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/66/10/2372/2191034/dkr316.pdf

Reference19 articles.

1. Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomized controlled trials

2. The Mechanism of Insulin Resistance Caused by HIV Protease Inhibitor Therapy

3. Drug-drug interactions in the treatment of HIV infection: focus on pharmacokinetic enhancement through CYP3A inhibition

4. Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers

5. Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive Patients

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive factors of viral load high-risk events for virological failure in HIV/AIDS patients receiving long-term antiviral therapy;BMC Infectious Diseases;2021-05-18

2. Response to letter to the editor;AIDS;2019-11-15

Durability of INI-containing regimens after switching from PI-containing regimens: a single-centre cohort of drug-experienced HIV-infected subjects

;Drug Design, Development and Therapy;2019-07

5. Long-term treatment with atazanavir (ATV) in real life in Belgium: a retrospective observational cohort of 2264 HIV patients;Acta Clinica Belgica;2018-05-02